Package 0006-3061-00

Brand: emend

Generic: fosaprepitant dimeglumine
NDC Package

Package Facts

Identity

Package NDC 0006-3061-00
Digits Only 0006306100
Product NDC 0006-3061
Product ID 0006-3061_20906e8e-8a3e-4c45-a657-6d4c1945af09
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)

Marketing

Marketing Status
Marketed Since 2017-02-03
Brand emend
Generic fosaprepitant dimeglumine
Sample Package No

Linked Drug Pages (0)

No linked drugs yet.

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "20906e8e-8a3e-4c45-a657-6d4c1945af09", "openfda": {"upc": ["0300063061001"], "unii": ["D35FM8T64X"], "rxcui": ["1731077", "1731082"], "spl_set_id": ["8d66803a-6811-4c29-9c57-e16acfa87f21"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00)  / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)", "package_ndc": "0006-3061-00", "marketing_start_date": "20170203"}], "brand_name": "EMEND", "product_id": "0006-3061_20906e8e-8a3e-4c45-a657-6d4c1945af09", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0006-3061", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMEND", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "NDA022023", "marketing_category": "NDA", "marketing_start_date": "20170203", "listing_expiration_date": "20271231"}